Roche Holding AG (VIE:ROGH)

Market Cap	307.15B +33.4%
Revenue (ttm)	68.05B +1.5%
Net Income	13.83B +55.6%
EPS	17.23 +55.6%
Shares Out	n/a
PE Ratio	22.20
Forward PE	17.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	388.20
Previous Close	390.80
Day's Range	386.80 - 390.20
52-Week Range	292.60 - 390.80
Beta	n/a
RSI	65.58
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ROGH

Financial Performance

In 2025, Roche Holding AG's revenue was 63.36 billion, an increase of 1.54% compared to the previous year's 62.40 billion. Earnings were 12.88 billion, an increase of 55.61%.

Financial numbers in CHF